WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-1.08%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$8.53B
AUM Growth
+$112M
(+1.3%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
3.98%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
809
New
193
Increased
196
Reduced
149
Closed
229
Top Buys
| 1 |
Analog Devices
ADI
|
$178M |
| 2 |
AbbVie
ABBV
|
$123M |
| 3 |
Electronic Arts
EA
|
$107M |
| 4 |
Autodesk
ADSK
|
$95.8M |
| 5 |
Keysight
KEYS
|
$82.3M |
Top Sells
| 1 |
HES
Hess
HES
|
$125M |
| 2 |
Amphenol
APH
|
$111M |
| 3 |
Cencora
COR
|
$106M |
| 4 |
Microsoft
MSFT
|
$99.2M |
| 5 |
Neurocrine Biosciences
NBIX
|
$95.5M |
Sector Composition
| 1 | Healthcare | 38.53% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Kenvue
KVUE
$35.7B
| $9.71M | 0.11% |
483,516
-231,457
| -32% | -$4.65M |
|
227
nCino
NCNO
$3.52B
| $9.64M | 0.11% |
303,254
+287,470
| +1,821% | +$9.14M |
|
228
Arbutus Biopharma
ABUS
$805M
| $9.58M | 0.11% |
4,719,903
+2,250,706
| +91% | +$4.57M |
|
|
VRNA
229
Verona Pharma
VRNA
$9.2B
| $9.56M | 0.11% |
586,722
+86,722
| +17% | +$1.41M |
|
230
CAVA Group
CAVA
$7.73B
| $9.52M | 0.11% |
310,766
+103,650
| +50% | +$3.17M |
|
231
Avery Dennison
AVY
$13.1B
| $9.41M | 0.11% |
51,497
+34,755
| +208% | +$6.35M |
|
232
Ralph Lauren
RL
$18.9B
| $9.41M | 0.11% |
81,019
+49,197
| +155% | +$5.71M |
|
|
LSXMA
233
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $9.39M | 0.11% |
368,879
-1,073,810
| -74% | -$27.3M |
|
234
Lattice Semiconductor
LSCC
$9.05B
| $9.38M | 0.11% |
+109,198
| New | +$9.38M |
|
|
SLRN
235
DELISTED
ACELYRIN
SLRN
| $9.23M | 0.11% |
907,913
-127,642
| -12% | -$1.3M |
|
236
Xponential Fitness
XPOF
$299M
| $9.11M | 0.11% |
587,549
+198,848
| +51% | +$3.08M |
|
237
Olema Pharmaceuticals
OLMA
$570M
| $8.86M | 0.1% |
717,332
+129,280
| +22% | +$1.6M |
|
238
Cheesecake Factory
CAKE
$3.02B
| $8.83M | 0.1% |
+291,550
| New | +$8.83M |
|
239
Viatris
VTRS
$12.2B
| $8.77M | 0.1% |
889,113
+76,613
| +9% | +$755K |
|
240
ATI
ATI
$10.7B
| $8.76M | 0.1% |
212,877
-231,797
| -52% | -$9.54M |
|
241
Cross Country Healthcare
CCRN
$462M
| $8.72M | 0.1% |
+351,720
| New | +$8.72M |
|
242
Structure Therapeutics
GPCR
$1.27B
| $8.57M | 0.1% |
170,000
| – | – |
|
243
CyberArk
CYBR
$23.3B
| $8.5M | 0.1% |
51,931
-71,105
| -58% | -$11.6M |
|
|
BLUE
244
DELISTED
bluebird bio
BLUE
| $8.3M | 0.1% |
136,437
+97,292
| +249% | +$5.92M |
|
245
Samsara
IOT
$24B
| $8.25M | 0.1% |
+327,338
| New | +$8.25M |
|
246
Advance Auto Parts
AAP
$3.63B
| $8M | 0.09% |
143,065
+59,012
| +70% | +$3.3M |
|
|
CEM
247
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $7.95M | 0.09% |
225,745
| – | – |
|
248
Soleno Therapeutics
SLNO
$3.71B
| $7.79M | 0.09% |
+263,860
| New | +$7.79M |
|
249
Phathom Pharmaceuticals
PHAT
$875M
| $7.67M | 0.09% |
740,021
+66,333
| +10% | +$688K |
|
250
Harmony Biosciences
HRMY
$2.07B
| $7.66M | 0.09% |
233,859
-6,357
| -3% | -$208K |
|